DAFSOLIMAB
UNII AO2W2OFG8P

Substance Identification & Data

This profile provides standardized clinical and technical data for Dafsolimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AO2W2OFG8P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2367001-71-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
AO2W2OFG8P
CAS Registry Number
2367001-71-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DAFSOLIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C175760
National Cancer Institute reference terminology for clinical and research data.
INN ID
11508
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dafsolimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DAFSOLIMAB

Common Names & Synonyms

DAFSOLIMAB [INN]
IMMUNOGLOBULIN G2B, ANTI-(HUMAN CD3 ANTIGEN .EPSILON..DELTA. COMPLEX) (MUS MUSCULUS MONOCLONAL SPV-T3A .GAMMA.2B-CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL SPV-T3A .KAPPA.-CHAIN, DIMER
MMUNOGLOBULIN G2B-KAPPA, ANTI-(CD3E (CD3 EPSILON, LEU-4)), MUS MUSCULUS MONOCLONAL ANTIBODY (DAFSOLIMAB)

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus